Seminars in Thrombosis and Hemostasis

Article	Citations
COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies	185
SARS-2 Coronavirus–Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?	71
Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis	71
Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy—Either, Neither, or Both	67
Venous Thromboembolism in Patients Discharged after COVID-19 Hospitalization	60
Recommendations for Minimal Laboratory Testing Panels in Patients with COVID-19: Potential for Prognostic Monitoring	54
Different Anticoagulant Regimens, Mortality, and Bleeding in Hospitalized Patients with COVID-19: A Systematic Review and an Updated Meta-Analysis	51
A Champion of Host Defense: A Generic Large-Scale Cause for Platelet Dysfunction and Depletion in Infection	44
Impaired Breakdown of Bradykinin and Its Metabolites as a Possible Cause for Pulmonary Edema in COVID-19 Infection	40
COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?	39
Platelets in Coronavirus Disease 2019	38
Hematology Laboratory Abnormalities in Patients with Coronavirus Disease 2019 (COVID-19)	38
Bleeding and Bleeding Risk in COVID-19	37
Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism	36
Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae	35
Temporal Changes in Fibrinolysis following Injury	34
Protective Effects of Statins Administration in European and North American Patients Infected with COVID-19: A Meta-Analysis	33
Diagnosis and Treatment of Trauma-Induced Coagulopathy by Viscoelastography	32
Thrombin Generation and Cirrhosis: State of the Art and Perspectives	32
Thrombin: A Pivotal Player in Hemostasis and Beyond	28
Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature	27
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease	25
Hormonal Contraceptives and the Risk of Venous Thrombosis	24
Presenting Characteristics, Treatment Patterns, and Outcomes among Patients with Venous Thromboembolism during Hospitalization for COVID-19	24
Relative Hypercoagulopathy of the SARS-CoV-2 Beta and Delta Variants when Compared to the Less Severe Omicron Variants Is Related to TEG Parameters, the Extent of Fibrin Amyloid Microclots, and the Se	24

Changes in Coagulation following Brain Injury	23
Pulmonary Megakaryocytes in Coronavirus Disease 2019 (COVID-19): Roles in Thrombi and Fibrosis	22
Platelets in Advanced Chronic Kidney Disease: Two Sides of the Coin	22
Mean Platelet Volume Predicts Severe COVID-19 Illness	21
The Role of Fibrin(ogen) in Wound Healing and Infection Control	21
Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-	21
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part I	21
Netting Liver Disease: Neutrophil Extracellular Traps in the Initiation and Exacerbation of Liver Pathology	20
Thromboelastography-Guided Management of Anticoagulated COVID-19 Patients to Prevent Hemorrhage	20
Thromboelastometry Variables in Neonates with Perinatal Hypoxia	20
Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease	19
Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes	18
Circulating Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Independent Predictors of Coronavirus Disease 2019 Severity: A Prospective, Observational Study	18
Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19)	18
Use of Glucocorticoids and Risk of Venous Thromboembolism: A Narrative Review	18
Rotational Thromboelastometry in Neonates Admitted to a Neonatal Intensive Care Unit: A Large Cross-sectional Study	18
Immune-Mediated Thrombotic Thrombocytopenic Purpura: A Narrative Review of Diagnosis and Treatment in Adults	18
The Role of Red Blood Cells in Hemostasis	18
Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More	17
Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19	17
Spontaneous Muscle Hematoma in Patients with COVID-19: A Systematic Literature Review with Description of an Additional Case Series	17
Oral Contraceptives and Venous Thromboembolism: Focus on Testing that May Enable Prediction and Assessment of the Risk	17
New Insights into the Pathogenesis, Risk Factors, and Treatment of Portal Vein Thrombosis in Patients with Cirrhosis	16
Iron Oxide Nanoparticles as Imaging and Therapeutic Agents for Atherosclerosis	16
A Review of Coagulation Abnormalities of Autoimmune Acquired Factor V Deficiency with a Focus on Japan	16
Biology of the Heparanase–Heparan Sulfate Axis and Its Role in Disease Pathogenesis	16
Perspectives on Platelet Heterogeneity and Host Immune Response in Coronavirus Disease 2019 (COVID-19)	16
Snake Venoms in Diagnostic Hemostasis and Thrombosis	15
Advances in the Management of Cancer-Associated Thrombosis	15
Incidence of Bleeding and Thrombosis in Patients with Liver Disease	15
Endothelial Heparan Sulfate Proteoglycans in Sepsis: The Role of the Glycocalyx	15
Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness	15
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II	15
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Pediatric Venous Thromboembolism Treatment and Thromboprophylaxis: A Systematic Review of the Literature	15
Fibrinolysis in Acute and Chronic Cardiovascular Disease	14
New-Onset Atrial Fibrillation in Sepsis: A Narrative Review	14
The Impact of SARS-CoV-2 Infection on Blood Coagulation and Fibrinolytic Pathways: A Review of Prothrombotic Changes Caused by COVID-19	14
Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders	14
Atypical Spontaneous Hematomas in a Patient with Severe Coronavirus Disease 2019 (COVID-19)	14
Platelet Function in Viral Immunity and SARS-CoV-2 Infection	13
Platelet Activation and Thrombosis in COVID-19	13
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)	13
Trauma-Induced Coagulopathy in Children	13
Dosage of Anticoagulants in Obesity: Recommendations Based on a Systematic Review	13
Thrombin Generation in Patients with Coronavirus Disease 2019	13
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part III	13
Fibrinolytic Alterations in Sepsis: Biomarkers and Future Treatment Targets	12
D-dimers—“Normal” Levels versus Elevated Levels Due to a Range of Conditions, Including “D-dimeritis,” Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-19	12
Contemporary Clinical Use of Aspirin: Mechanisms of Action, Current Concepts, Unresolved Questions, and Future Perspectives	12
Profile of Patients with Isolated Distal Deep Vein Thrombosis versus Proximal Deep Vein Thrombosis or Pulmonary Embolism: RE-COVERY DVT/PE Study	12

Arterial Thrombotic Events in Hospitalized COVID-19 Patients: A Short Review and Meta-Analysis	12
The More Recent History of Hemophilia Treatment	12
Direct Oral Anticoagulants Plasma Levels Measurement: Clinical Usefulness from Trials and Real-World Data	12
Disseminated Intravascular Coagulation: The Past, Present, and Future Considerations	12
Immune-Mediated Coagulopathy in COVID-19 Infection	12
Viscoelastic Tests as Point-of-Care Tests in the Assessment and Management of Bleeding and Thrombosis in Liver Disease	12
Mutations Accounting for Congenital Fibrinogen Disorders: An Update	12
Sulodexide versus Control and the Risk of Thrombotic and Hemorrhagic Events: Meta-Analysis of Randomized Trials	11
Anti-Xa Monitoring of Low-Molecular-Weight Heparin during Pregnancy: A Systematic Review	11
Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis	11
Evaluating Performance of Contemporary and Historical von Willebrand Factor (VWF) Assays in the Laboratory Identification of von Willebrand Disease (VWD): The Australasian Experience	11
Pharmacotherapy for Prevention and Management of Thrombosis in COVID-19	11
COVID-19 and Sex-/Gender-Specific Differences: Understanding the Discrimination	11
Testing for Lupus Anticoagulants	11
Utilization of the Caprini Score for Risk Stratification of the Arthroplasty Patient in the Prevention of Postoperative Venous Thrombosis	11
Platelets and Fibrinogen: Emerging Complexity in Trauma-Induced Coagulopathy	11
Emerging Roles of Heparan Sulfate Proteoglycans in Viral Pathogenesis	11
Current Challenges in the Peripartum Management of Women with von Willebrand Disease	11
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies	11
Solid Phase Assays for Antiphospholipid Antibodies	11
Laboratory Diagnosis of von Willebrand Disease (VWD): Geographical Perspectives	10
The Biological Significance of von Willebrand Factor O-Linked Glycosylation	10
Hyperfibrinolysis in Patients with Solid Malignant Neoplasms: A Systematic Review	10
Does Chronic Treatment with Oral Anticoagulants Ameliorate the Clinical Course of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Coronavirus Disease 2019 (COVID-19)?	10
Whole Blood for Civilian Urban Trauma Resuscitation: Historical, Present, and Future Considerations	10
Platelet Count and Function during Pediatric Extracorporeal Membrane Oxygenation	10
Fibrinolysis in Patients with Liver Disease	10
Systemic Antiangiogenic Therapies for Bleeding in Hereditary Hemorrhagic Telangiectasia: A Practical, Evidence-Based Guide for Clinicians	10
Fibrinolysis in Traumatic Brain Injury: Diagnosis, Management, and Clinical Considerations	10
Single, Dual, and Triple Antithrombotic Therapy in Cancer Patients with Coronary Artery Disease: Searching for Evidence and Personalized Approaches	10
To Anticoagulate or Not to Anticoagulate in COVID-19: Lessons after 2 Years	10
The Benefits of Heparin Use in COVID-19: Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties	10
Involvement of Inflammation in Venous Thromboembolic Disease: An Update in the Age of COVID-19	10
Why, Whom, and How to Screen for Chronic Thromboembolic Pulmonary Hypertension after Acute Pulmonary Embolism	10
Platelet Function and Turnover in Essential Thrombocythemia: A Systematic Review	10
Hemostasis and Liver Regeneration	10
ROTEM Testing for Direct Oral Anticoagulants	9
What We Know (and Do not Know) Regarding the Pathogenesis of Pulmonary Thrombosis in COVID-19	9
Oxford-AstraZeneca ChAdOx1 COVID-19 Vaccine Does Not Alter Platelet Aggregation	9
Laboratory Testing for Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia Antibodies: A Narrative Review	9
Impaired Fibrinolysis in the Antiphospholipid Syndrome	9
Type 2A and 2M von Willebrand Disease: Differences in Phenotypic Parameters According to the Affected Domain by Disease-Causing Variants and Assessment of Pathophysiological Mechanisms	9
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles	9
Gene Therapy for Inherited Bleeding Disorders	9
Clinical Performance of Nonvitamin K Antagonist Oral Anticoagulants in Real-World Obese Patients with Atrial Fibrillation	9
Post COVID-19 Arterial Thromboembolism: A Clear and Present Danger	9
Type 2B von Willebrand Disease in Pregnancy: A Systematic Literature Review	9
The Art and Science of Building a Computational Model to Understand Hemostasis	9
2020 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles	8
Cancer-Associated Splanchnic Vein Thrombosis	8
The Spectrum of Disease Severity in Cirrhosis and Its Implications for Hemostasis	8
Tranexamic Acid and Its Potential Anti-Inflammatory Effect: A Systematic Review	8
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review	8
The Clotting Trigger Is an Important Determinant for the Coagulation Pathway In Vivo or In Vitro—Inference from Data Review	8
Cerebral Venous Thrombosis	8
The Complexity of Trauma-Induced Coagulopathy	8
Mechanisms of Bone Remodeling Disorder in Hemophilia	8
Venous Thromboembolism among Critically Ill Children: A Narrative Review	8
Effect of Multiple Freeze–Thaw Cycles on Coagulation Testing	7
The Role of Epigenetics in the Regulation of Hemostatic Balance	7
Increased Levels of Inflammatory and Endothelial Biomarkers in Blood of Long COVID Patients Point to Thrombotic Endothelialitis	7
Venous Thromboembolism in Pediatric Cancer Patients with Central Venous Catheter—A Systematic Review and Meta-analysis	7
2020 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards	7
Platelet Function Testing: Update and Future Directions	7
Heparin: The Journey from Parenteral Agent to Nasal Delivery	7
Cancer-Related Venous Thromboembolism: From Pathogenesis to Risk Assessment	7
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part I	7
Post-Pulmonary Embolism Syndrome and Functional Outcomes after Acute Pulmonary Embolism	7
Altered Fibrinolysis in Hematological Malignances	7
Efficacy and Safety of D-dimer, Weight, and Renal Function-Adjusted Thromboprophylaxis in Patients with Coronavirus Disease 2019 (COVID-19)	7
Rivaroxaban Compared to Placebo for the Treatment of Leg Superficial Vein Thrombosis: A Randomized Trial	7
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)—Part IV	7
Passive Immunity for Coronavirus Disease 2019: A Commentary on Therapeutic Aspects Including Convalescent Plasma	7
Hemostatic Biomarkers and Cancer Prognosis: Where Do We Stand?	7
Fibrinolysis in Venous Thromboembolism	7
Challenges in the Production of Convalescent Hyperimmune Plasma in the Age of COVID-19	7
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications	7
Role of Circulating Microparticles in Type 2 Diabetes Mellitus: Implications for Pathological Clotting	6
Point-of-Care Diagnostic Assays and Novel Preclinical Technologies for Hemostasis and Thrombosis	6
One Hundred Years of Congenital Fibrinogen Disorders	6

Risk of Bleeding during Implant Surgery in Patients Taking Antithrombotics: A Systematic Review	6
Impact of Thrombosis and Bleeding in Patients with Severe COVID-19 versus Other Viral Pneumonias in the Context of Extracorporeal Membrane Oxygenation	6
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment	6
Analysis of College of American Pathologists von Willebrand Factor Proficiency Testing Program	6
Acquired Thrombotic Thrombocytopenic Purpura: A Rare Coincidence after COVID-19 mRNA Vaccine?	6
Risk Assessment Models for Thrombosis and Anticoagulant-Related Bleeding in Ambulatory Cancer Patients	6
Risk and Management of Intracerebral Hemorrhage in Patients with Bleeding Disorders	6
Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy: Risk Factors and Prevention	6
Anticoagulant Management and Synthesis of Hemostatic Proteins during Machine Preservation of Livers for Transplantation	6
2022 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles	6
Viscoelastic Testing in the Management of Adult Patients on Mechanical Circulatory Support Devices with Focus on Extracorporeal Membrane Oxygenation	6
Dynamic Hemostasis and Fibrinolysis Assays in Intensive Care COVID-19 Patients and Association with Thrombosis and Bleeding—A Systematic Review and a Cohort Study	6
Right Atrial Thrombosis and Pulmonary Embolism: A Narrative Review	6
Rotational Thromboelastometry Predicts Transfusion Requirements in Total Joint Arthroplasties	6
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part II	6
Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease	6
Effect of Heparanase and Heparan Sulfate Chains in Hemostasis	6
The Current Role of Platelet Function Testing in Clinical Practice	6
50 Years of Pediatric Hemostasis: Knowledge, Diagnosis, and Treatment	6
MiRNA 126 as a New Predictor Biomarker in Venous Thromboembolism of Persistent Residual Vein Obstruction: A Review of the Literature Plus a Pilot Study	6
2021 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles	6
The Growing Impact of Cardiovascular Oncology: Epidemiology and Pathophysiology	6
Blood Markers of Portal Hypertension Are Associated with Blood Loss and Transfusion Requirements during Orthotopic Liver Transplantation	6
Anabolic–Androgenic Steroid Abuse Impairs Fibrin Clot Lysis	6
Influence of Tranexamic Acid on Inflammatory Signaling in Trauma	6
Increased Platelet Activation demonstrated by Elevated CD36 and P-Selectin Expression in 1-Year Post-Recovered COVID-19 Patients	6
The Utility of NATEM Assay in Predicting Bleeding Risk in Critically Ill Neonates	5
Interaction between Antiphospholipid Antibodies and Protein C Anticoagulant Pathway: A Narrative Review	5
The Post–Venous Thromboembolism Functional Status Scale: From Call to Action to Application in Research, Extension to COVID-19 Patients, and Its Use in Clinical Practice	5
Protamine—The Journey from DNA to Heparin Neutralization to Gene therapy	5
The Central Role of Acute Phase Proteins in Rheumatoid Arthritis: Involvement in Disease Autoimmunity, Inflammatory Responses, and the Heightened Risk of Cardiovascular Disease	5
Clot Waveform Analysis for Monitoring Hemostasis	5
Use of Direct Oral Anticoagulants in People Living with HIV: A Single-Center Experience	5
New-Onset Atrial Fibrillation and Adverse In-Hospital Outcome in Patients with Acute Pulmonary Embolism	5
Tranexamic Acid Treatment for Trauma Victims	5
Physicians' Opinions on Anticoagulant Therapy in Patients with a Limited Life Expectancy	5
Mechanisms of Thrombosis in Heparin-Induced Thrombocytopenia and Vaccine-Induced Immune Thrombotic Thrombocytopenia	5
Is Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein a Potential Basis for Autoimmune Responses in Vaccinated and Naturally Infected Patients?	5
Altered Fibrinolysis during and after Surgery	5
The Choice between Plasma-Based Common Coagulation Tests and Cell-Based Viscoelastic Tests in Monitoring Hemostatic Competence: Not an either–or Proposition	5
Heparan Sulfate Proteoglycans in Diabetes	5
Sustained High D-Dimer in Outpatients Who Have Recovered from Mild to Moderate Coronavirus Disease 2019 (COVID-19)	5
Factor VIII and Factor IX Activity Measurements for Hemophilia Diagnosis and Related Treatments	5
Acquired Platelet Dysfunction—Laboratory and Clinical Implications	5
Reversal Agents for the Direct Factor Xa Inhibitors: Biochemical Mechanisms of Current and Newly Emerging Therapies	5
Diagnostic Testing for von Willebrand Disease: Trends and Insights from North American Laboratories over the Last Decade	5
Acquired Factor V Inhibitor after Coronavirus Disease 2019 (COVID-19)	5
Catheter-Directed Thrombolysis in a Patient with Severe COVID-19 Pneumonia on Extracorporeal Membrane Oxygenation	5
The Role of Plasminogen Activator Inhibitor Type 1 (PAI-1) in Placenta-Mediated Pregnancy Complications: A Systematic Review	5
A Review of Autoimmune Acquired von Willebrand Factor Deficiency in Japan	5
Relevance of Heparan Sulfate and Heparanase to Severity of COVID-19 in the Elderly	5
Dysfibrinogenemia—Potential Impact of Genotype on Thrombosis or Bleeding	5
Research Trends in Anticoagulation Therapy over the Last 25 Years	4
From the Discovery of ADAMTS13 to Current Understanding of Its Role in Health and Disease	4
Does COVID-19 Provide a Clue for Thrombosis in ITP?	4
The Case for Therapeutic-Intensity Anticoagulation in Patients with COVID-19-Associated Moderate Illness	4
Resonant Acoustic Rheometry to Measure Coagulation Kinetics in Hemophilia A and Healthy Plasma: A Novel Viscoelastic Method	4
2023 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles	4
Three-Dimensional Human Neural Stem Cell Models to Mimic Heparan Sulfate Proteoglycans and the Neural Niche	4
Shortcomings in Design and Analysis of Clinical Studies on Bleeding and Thrombosis in Patients with Cirrhosis	4
From Ink Pens to Computers: A Personal Look Back at Landmark Changes during 5 Decades as a Clinical Laboratory Scientist in U.S. Hemostasis Laboratories	4
Toward 50 Years of Seminars in Thrombosis and Hemostasis	4
Pulmonary Embolism and Chronic Obstructive Pulmonary Disease	4
Causal Associations Between Cardiovascular Risk Factors and Venous Thromboembolism	4
The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review	4
Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's Disease	4
Fibrinolysis Shutdown and Hypofibrinolysis Are Not Synonymous Terms: The Clinical Significance of Differentiating Low Fibrinolytic States	4
Strength of Anticoagulation in Moderate to Severe COVID-19 Illness: In Medio Stat Virtus?	4
Efficacy and Safety of Antifibrinolytic Drugs in Pediatric Surgery: A Systematic Review	4
Neurocoagulation from a Mechanistic Point of View in the Central Nervous System	4
Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings	4
Low-Molecular-Weight Heparin Resistance and Its Viscoelastic Assessment in Critically Ill COVID-19 Patients	4
Genomic Analysis for the Detection of Bleeding and Thrombotic Disorders	4
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies	4
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art	4
The History of Extracorporeal Membrane Oxygenation and the Development of Extracorporeal Membrane Oxygenation Anticoagulation	4
Frequency and Clinical Significance Anti-PS/PT Antibodies in Patients with Antiphospholipid Syndrome—Single Centre Observational Study in the United Kingdom	3
Fifty Years of Fibrinogen Structure and Function	3
Hemostatic and Nonhemostatic Effects of Heparan Sulfate Proteoglycans	3
Assessment of Hemostatic Profile in Neonates with Intrauterine Growth Restriction: A Systematic Review of Literature	3
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey	3
A Historical Perspective on the Reversal of Anticoagulants	3
Antiphospholipid Syndrome in Patients with Venous Thromboembolism	3
Preface: Altered Fibrinolysis—Clinical Impact and Diagnostic Challenges	3
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance	3
Proposal for a Simple Algorithmic Approach to Manage Drug–Drug Interactions of Oral Anticoagulants with Nirmatrelvir/Ritonavir in COVID-19 Outpatients	3
Early Resolution of Heyde's Syndrome following Transcatheter Aortic Valve Replacement	3
Pathogen Reduction Technologies and Their Impact on Metabolic and Functional Properties of Treated Platelet Concentrates: A Systematic Review	3
Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease	3
Clinical Studies with Anticoagulants that Have Changed Clinical Practice	3
Hypercoagulability and Thrombosis Risk in Prostate Cancer: The Role of Thromboelastography	3
Von Willebrand Factor Multimer Analysis and Classification: A Comprehensive Review and Updates	3
Doctor, Do I Have Lupus? Time to Reconsider the Lupus Anticoagulant Terminology	3
Upper Extremity Deep Vein Thrombosis: Current Knowledge and Future Directions	3
The Role of Thromboelastography during the Management of Postpartum Hemorrhage: Background, Evidence, and Practical Application	3